Two more experimental vaccines to fight the novel Covid-19 have been approved for clinical trials in China on Tuesday (April 14).
Wu Yuanbin, an official from China's Ministry of Science and Technology said in a press briefing that the vaccines use inactivated Covid-19 pathogens, and it is now ready and approved for early-stage human trials.
Photo source: New Straits Times
Wu told the press that another vaccine was approved on Monday (April 13) by China's state food and drug administration. The vaccine was developed by the Beijing-based unit of Nasdaq-listed Sinovac Biotech.
He added that the Wuhan Institute of Biological Products and Wuhan Institute of Virology have also developed the vaccine and was approved on Sunday (April 12).
While another vaccine developed by the Military Medical Sciences and Hong Kong-listed firm CanSino Bio was approved earlier on March 16, which has now entered Phase II of clinical studies.
All in all, China has now 3 possible Covid-19 vaccines undergoes clinical trials.
Let's hope that good news would come from these trials!
News source from the New Straits Times.
